CD31 (PECAM-1) is a marker of recent thymic emigrants among CD4+ T-cells, but not CD8+ T-cells or γ δ T-cells, in HIV patients responding to ART

Immunology and Cell Biology

Volumn 88, Issue 3, 2010, Pages 321-327

  Tanaskovic, Sara ^a   Fernandez, Sonia ^a   Price, Patricia ^a,b   Lee, Silvia ^a,b   French, Martyn A ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD31 ANTIGEN; CD45RA ANTIGEN; CELL MARKER; T LYMPHOCYTE RECEPTOR;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ANTIGEN EXPRESSION; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MALE; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; SUPPRESSOR CELL; THYMUS FUNCTION; TREATMENT RESPONSE; VIROLOGY;

ADULT; ANTIGENS, CD31; ANTIGENS, CD45; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CD8-POSITIVE T-LYMPHOCYTES; CELL MOVEMENT; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOPOIESIS; MALE; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTES, REGULATORY; THYMUS GLAND; TOMOGRAPHY, SPIRAL COMPUTED;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 77949873776     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2009.108     Document Type: Article

References (26)

1. Pakker NG, Notermans DW, de Boer RJ, Roos MT, de Wolf F, Hill A et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998; 4: 208-214.
2. Roederer M. Getting to the HAART of T cell dynamics. Nat Med 1998; 4: 145-146.
3. Fernandez S, Nolan RC, Price P, Krueger R, Wood C, Cameron D et al. Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy. AIDS Res Hum Retroviruses 2006; 22: 163-170.
4. Mussini C, Pinti M, Borghi V, Nasi M, Amorico G, Monterastelli E et al. Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy. AIDS 2002; 16: 1609-1616.
5. Douek D. Thymic output and HIV infection: on the right TREC. Immunity 2004; 21: 744-745.
6. Ye P, Kirschner DE. Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants. J Immunol 2002; 168: 4968-4979.
7. Vrisekoop N, den Braber I, de Boer AB, Ruiter AF, Ackermans MT, van der Crabben SN et al. Sparse production but preferential incorporation of recently produced naive T cells in the human peripheral pool. Proc Natl Acad Sci USA 2008; 105: 6115-6120.
8. Bofill M, Martinez-Picado J, Ruiz-Hernandez R, Cabrera C, Marfil S, Erkizia I et al. Naive CD4(+) T cells and recent thymic emigrant levels in treated individuals with HIV: clinical relevance. AIDS Res Hum Retroviruses 2006; 22: 893-896.
9. Brenchley JM, Hill BJ, Ambrozak DR, Price DA, Guenaga FJ, Casazza JP et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J Virol 2004; 78: 1160-1168.
10. Haas J, Fritzsching B, Trubswetter P, Korporal M, Milkova L, Fritz B et al. Prevalence of newly generated naive regulatory T cells (Treg) is critical for Treg suppressive function and determines Treg dysfunction in multiple sclerosis. J Immunol 2007; 179: 1322-1330.
11. Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A et al. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002; 195: 789-794.
12. Nickel P, Kreutzer S, Bold G, Friebe A, Schmolke K, Meisel C et al. CD31+ naive Th cells are stable during six months following kidney transplantation: implications for post-transplant thymic function. Am J Transplant 2005; 5: 1764-1771.
13. Junge S, Kloeckener-Gruissem B, Zufferey R, Keisker A, Salgo B, Fauchere JC et al. Correlation between recent thymic emigrants and CD31+ (PECAM-1) CD4+ T cells in normal individuals during aging and in lymphopenic children. Eur J Immunol 2007; 37: 3270-3280.
14. Demeure CE, Byun DG, Yang LP, Vezzio N, Delespesse G. CD31 (PECAM-1) is a differentiation antigen lost during human CD4 T-cell maturation into Th1 or Th2 effector cells. Immunology 1996; 88: 110-115.
15. Stockinger H, Schreiber W, Majdic O, Holter W, Maurer D, Knapp W. Phenotype of human T cells expressing CD31, a molecule of the immunoglobulin supergene family. Immunology 1992; 75: 53-58.
16. Kohler S, Thiel A. Life after the thymus: CD31+ and CD31- human naive CD4+ T-cell subsets. Blood 2009; 113: 769-774.
17. Tanaka Y, Albelda SM, Horgan KJ, van Seventer GA, Shimizu Y, Newman W et al. CD31 expressed on distinctive T cell subsets is a preferential amplifier of beta 1 integrinmediated adhesion. J Exp Med 1992; 176: 245-253.
18. Torimoto Y, Rothstein DM, Dang NH, Schlossman SF, Morimoto C. CD31, a novel cell surface marker for CD4 cells of suppressor lineage, unaltered by state of activation. J Immunol 1992; 148: 388-396.
19. Cao W, Jamieson BD, Hultin LE, Hultin PM, Effros RB, Detels R. Premature aging of T cells is associated with faster HIV-1 disease progression. J Acquir Immune Defic Syndr 2009; 50: 137-147.
20. Kilpatrick RD, Rickabaugh T, Hultin LE, Hultin P, Hausner MA, Detels R et al. Homeostasis of the naive CD4+ T cell compartment during aging. J Immunol 2008; 180: 1499-1507.
21. Azevedo RI, Soares MV, Barata JT, Tendeiro R, Serra-Caetano A, Victorino RM et al. IL-7 sustains CD31 expression in human naive CD4+ T cells and preferentially expands the CD31+ subset in a PI3K-dependent manner. Blood 2009; 113: 2999-3007.
22. Ishikawa H, Naito T, Iwanaga T, Takahashi-Iwanaga H, Suematsu M, Hibi T et al. Curriculum vitae of intestinal intraepithelial T cells: their developmental and behavioral characteristics. Immunol Rev 2007; 215: 154-165.
23. Poccia F, Battistini L, Cipriani B, Mancino G, Martini F, Gougeon ML et al. Phosphoantigen- reactive Vgamma9Vdelta2T lymphocytes suppress in vitro human immunodeficiency virus type 1 replication by cell-released antiviral factors including CC chemokines. J Infect Dis 1999; 180: 858-861.
24. Boullier S, Cochet M, Poccia F, Gougeon ML. CDR3-independent gamma delta V delta 1+ T cell expansion in the peripheral blood of HIV-infected persons. J Immunol 1995; 154: 1418-1431.
25. Kagnoff MF. Current concepts in mucosal immunity. III. Ontogeny and function of gamma delta T cells in the intestine. Am J Physiol 1998; 274: G455-G458.
26. De Rossi A, Walker AS, Klein N, De Forni D, King D, Gibb DM. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. J Infect Dis 2002; 186: 312-320.